GE Healthcare Innova IGS 3 (GTIN 00840682147378)…

Date

June 23, 2021

Risk class

Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)

Status

Terminated

Filed by

GE Healthcare, LLC

Product

GE Healthcare Innova IGS 3 (GTIN 00840682147378), Innova IGS 5 (GTIN 00840682124621), Innova IGS 6 (GTIN 00840682124614), Discovery IGS 7 (GTIN 00840682124638), and Discovery IGS 7 OR (GTIN00840682125888) interventional fluoroscopic x-ray systems.

Reason

The IGS system can experience a single vertical line defect where the vertical line divides and horizontally shifts live monitor images into two unequal image parts within the monitor display screen.

Distribution pattern

Worldwide distribution - US Nationwide distribution in the states of CA, CO, FL, GA, KY, LA, MA, MO, MS, NC, NJ, NV, NY, PA, SC, TN, TX, VA, WA, and WI. Government distribution was made and potentially military distribution was made. The countries of Algeria, Argentina, Canada, China, Dominican Republic, Finland, France, Germany, Hungary, India, Indonesia, Iran, Iraq, Italy, Japan, Korea, Kuwait, Mexico, Moldova, Morocco, Poland, Russia, Spain, Sudan, Taiwan, Turkey, United Arab Emirates, United Kingdom, and Uzbekistan.

Quantity

139 devices

Codes and lots

Affected serial numbers: B2-20-006, B2-20-007, B2-20-008, B2-20-009, B2-21-001, B3-20-024, B3-20-026, B3-20-027, B3-20-028, B3-21-001, B3-21-002, B3-21-003, B3-21-006, D3-20-025, D3-20-028, D3-20-029, D3-21-002, D3-21-005, D3-21-006, D3-21-007, D3-21-008, D3-21-009, D4-20-025, D4-20-026, D4-20-029, D4-20-031, D4-20-032, D4-20-033, D4-21-003, D4-21-004, D4-21-005, D4-21-007, D4-21-008, D4-21-010, M2-20-040, M2-20-041, M2-20-042, M2-20-043, M2-20-045, M2-20-046, M2-20-047, M2-20-048, M2-20-049, M2-20-050, M2-20-051, M2-20-052, M2-20-053, M2-20-054, M2-21-003, M2-21-004, M2-21-005, M2-21-006, M2-21-007, M2-21-008, M2-21-009, M2-21-010, M2-21-012, M2-21-013, M2-21-014, M3-20-094, M3-20-095, M3-20-096, M3-20-098, M3-20-101, M3-20-105, M3-20-108, M3-20-110, M3-20-114, M3-20-116, M3-20-118, M3-20-119, M3-20-120, M3-20-122, M3-20-123, M3-20-124, M3-20-125, M3-20-126, M3-20-127, M3-21-001, M3-21-006, M3-21-007, M3-21-009, M3-21-010, M3-21-011, M3-21-012, M3-21-013, M3-21-014, M3-21-015, M3-21-016, M3-21-017, M3-21-019, M3-21-020, M3-21-023, M3-21-024, M3-21-026, M3-21-027, M3-21-028, M4-20-022, M4-20-023, M4-20-026, M4-20-028, M4-20-029, M4-20-030, M4-20-033, M4-20-034, M4-20-035, M4-20-036, M4-20-039, M4-20-041, M4-21-001, M4-21-002, M4-21-004, M4-21-005, M4-21-006, M4-21-007, M4-21-008, M4-21-009, M4-21-011, M4-21-012, M4-21-013, M4-21-014, M4-21-015, M4-21-016, and M4-21-017. Serial numbers that are under GE control but are consigned to a facility and not yet installed: D4-21-009, M3-21-022, M3-21-008, B3-21-005, D3-21-003, M3-21-025, M2-20-044, M3-21-029 D3-20-027, M2-21-011, and M3-21-021.

Recall started

April 19, 2021

Device type

Interventional Fluoroscopic X-Ray System

Root cause (FDA)

Component change control

What the company told customers

The recalling firm issued letters dated 4/19/2021 via traceable mail on 4/20/21 and issued an additional letter dated 4/28/2021 to correct an omission of serial numbers (only sent to the affected consignees).

Recall number

Z-1864-2021

What should I do? How serious is a recall? Classes and warnings explained

Source: FDA · Medical device enforcement report, recall number Z-1864-2021. The agency record governs; check it and the company before acting.